The evolution of amidine-based brain penetrant BACE1 inhibitors
Authors:
Open Access
- 1 May 2014
- journal article
- review article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (9) , 2033-2045
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- BACE1 in Alzheimer's diseaseClinica Chimica Acta, 2012
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive declineNature, 2012
- Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)Expert Opinion on Therapeutic Patents, 2012
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeuticsNature Reviews Drug Discovery, 2011
- Amyloid: Little proteins, big cluesNature, 2011
- The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's diseaseAlzheimer's Research & Therapy, 2011
- Beta-Secretase: Structure, Function, and EvolutionCNS & Neurological Disorders - Drug Targets, 2008
- Mechanisms of Aβ mediated neurodegeneration in Alzheimer's diseaseThe International Journal of Biochemistry & Cell Biology, 2008
- Testing times for the “amyloid cascade hypothesis”Neurobiology of Aging, 2002
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992